Home » Biotechnology » Page 3

Tag

Biotechnology

News

Phico Therapeutics completes £1 million fundraising

Cambridge-based Phico Therapeutics has completed a £1 million fundraising round to help develop products that treat E. coli bacteria.

News

AstraZeneca and Heptares collaborate on drug development

AstraZeneca and Heptares Therapeutics have entered a four-year collaboration focused on the development of new drugs targeting proteins.

News

Private placing raises £25 million for Oxford Nanopore

Biotech developer Oxford Nanopore Technologies has raised £25 million in a latest financing round.

News

Viropro acquires biotech production facility

US-based biopharmaceutical company Viropro has acquired a Cambridge biotech facility in a deal worth $21 million (£13 million).

News

Mercia launches new biotech company

Seed investor The Mercia Fund has spun out a new venture, the Native Antigen Company (NAC), from existing portfolio company PsiOxus Therapeutics.

News

Oxford biotech spin-out raises £1.55 million

Crysalin, a spin-out from the University of Oxford's biochemistry department, has secured equity finance of £1.55 million.

News

Biotech start-ups starved of cash

Most of the UK's biotech start-ups receive no external funding, and the problem is particularly acute outside the South East, finds research.

News

Oxford Nanopore raises £17.4 million

New and existing investors have backed nanotechnology business Oxford Nanopore with an investment of £17.4 million.

News

Curzon Park leads Q Chip investment 

Biotech company Q Chip has received £1 million in a funding round led by cleantech venture investor Curzon Park Capital.

News

Source BioScience on the rebound

Healthcare and pharmaceutical services provider Source BioScience is mooting acquisitions after turning a £181,000 interim loss into £62,000 pre-tax profits.

News

German biotech sector booming

Germany's biotech sector has continued its strong run in 2008.

News

UCL spin-out Domainex raises £1 million

Domainex, a biopharmaceutical spin-out from University College London (UCL), has raised £1 million to develop its contract research business and commercialise its drug discovery projects.

Recommended Content